Partnering

Cloud Pharmaceuticals works with partners at all stages of drug development including early stage, preclinical, IND, and the clinic. We are currently engaged in drug discovery and development programs spanning a wide range of indications including:

• Autism, Alzheimer's, and other neurodegenerative disorders
• Cancer, solid tumor and hematologic, including lymphoma, fibrosis, blood cancers, lung cancer, etc.
• Inflammation, rheumatoid arthritis, sarcopenia
• Kidney disease
• Orphan diseases including malaria, Dengue fever, and Chagas disease
• Metabolic disorders, lipid metabolism, etc.
• Respiratory diseases and chronic obstructive pulmonary disease (COPD)